FDA, Merck, and Vioxx
Subtitle: putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, November 18, 2004
Series: S. hrg -- 108-791
Publisher: U.S. G.P.O.; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 2005
Place of publication: Washington
Language: eng
Number of pages: 921
Subjects: Merck & Co. -- Corrupt practices; Rofecoxib; Drug monitoring -- United States; Drugs -- United States -- Testing
Notes: Distributed to some depository libraries in microfiche

Includes bibliographical references